European IP Bulletin -- Issue 90, May 2012


In This Issue:


Court of Appeal of England and Wales Allows Damages Under a Cross-Undertaking in Respect of an Interim Injunction; Advocate General Recommends Dismissal of AstraZeneca Appeal; and Advocate General Opinion on The Interpretation of “First Marketing Authorisation” for Supplementary Protection Certificates.


Court of Justice of the European Union Considers Whether Unfair Terms and Practices Invalidate Agreements.

Data Protection:

90,000 Reasons To Consider Ongoing Data Protection Training as Critical.


Protection of Computer Programs Revisited by the Court of Justice of the European Union.

General Intellectual Property:

OHIM Tasked with IP Infringement Monitoring Role.


Counterclaims for The Invalidity of a Community Trade Mark Are a Shield, Not a Sword.

Please see full issue below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Written by:

Published In:

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McDermott Will & Emery | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.